According to MiNK Therapeutics's latest financial reports the company has $5.81 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $19.63 M | -49.51% |
2021-12-31 | $38.88 M | 1345.06% |
2020-12-31 | $2.69 M | 799.94% |
2019-12-31 | $0.29 M |